Rigel Pharmaceuticals (RIGL) Goodwill & Intangibles (2022 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Goodwill & Intangibles of $24.2 million for Q1 2026, down 8.87% year-over-year from $26.5 million in Q1 2025, and down 2.38% quarter-over-quarter from $24.7 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $24.2 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 8.87% year-over-year to $24.2 million; the TTM figure through Mar 2026 stood at $24.2 million (down 8.87% YoY), while the FY2025 annual figure was $24.7 million, down 8.68% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $24.2 million, down from $24.7 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $28.9 million in Q1 2024, with the low at $13.9 million in Q4 2023.
- The 5-year median for Goodwill & Intangibles is $25.0 million (2025), against an average of $22.2 million.
- The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles surged 96.6% in 2024, then slipped 8.87% in 2026.
- Rigel Pharmaceuticals' Goodwill & Intangibles stood at $15.0 million in 2022, then fell by 7.48% to $13.9 million in 2023, then surged by 95.27% to $27.1 million in 2024, then dropped by 8.68% to $24.7 million in 2025, then retreated by 2.38% to $24.2 million in 2026.
- Business Quant data shows RIGL's Goodwill & Intangibles at $24.2 million in Q1 2026, $24.7 million in Q4 2025, and $25.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.88 Mn |
| Mar 31, 2026 | 24.16 Mn |
| Dec 31, 2025 | 24.75 Mn |
| Sep 30, 2025 | 25.34 Mn |
| Jun 30, 2025 | 25.92 Mn |
| Mar 31, 2025 | 26.51 Mn |
| Dec 31, 2024 | 27.10 Mn |
| Sep 30, 2024 | 27.69 Mn |
| Jun 30, 2024 | 28.28 Mn |
| Mar 31, 2024 | 28.86 Mn |
| Dec 31, 2023 | 13.88 Mn |
| Sep 30, 2023 | 14.15 Mn |
| Jun 30, 2023 | 14.41 Mn |
| Mar 31, 2023 | 14.68 Mn |
| Dec 31, 2022 | 15.00 Mn |